Advanced Engineered Materials is targeting a sharp increase in high-purity alumina sales while laying the groundwork for a possible doubling of Cap-Chat capacity to 6,000 tonnes per annum. The opportunity is substantial, but much of the customer pipeline remains uncontracted and the expansion still depends on feasibility work, financing and a final investment decision.
- 225 customer qualification projects at the end of August
- Second-half 2026 sales forecast at approximately 40-60 tonnes
- Cap-Chat capacity targeted to reach 3,000 tonnes per annum in 2026
- Stage 2 expansion would lift total capacity to 6,000 tonnes per annum from 2029
- A$23.7 million cash balance at 30 June 2026
Customer pipeline grows faster than current sales
Advanced Engineered Materials Ltd (ASX:AEM) is presenting a much larger commercial opportunity than its current sales base, with 225 high-purity alumina projects in qualification at the end of August. That pipeline includes 38 industrial trials, 18 projects that have completed qualification and entered commercial relationships, and 169 laboratory-stage projects.
The numbers are encouraging, but they are not an order book. AEM says the aggregate project scope is un-risked, and projects may fail qualification, be delayed, change scale or never convert into sales. The company’s immediate test is therefore more concrete: it expects second-half 2026 sales of approximately 40 to 60 tonnes, compared with 12.5 tonnes sold for A$460,000 in the first half.
Cap-Chat ramp points towards a larger plant
The Cap-Chat plant in Quebec currently has 2,000 tonnes per annum of nameplate capacity and has been modified to produce ultra-low alpha alumina for semiconductor applications. AEM is adding a dedicated 3N5+ circuit that is expected to lift installed capacity to 3,000 tonnes per annum by the end of 2026, with the 4N+ circuit targeted to reach full run rate by the end of 2027 and the 3N5+ circuit by mid-2028.
The company’s longer-term plan is more ambitious: a Stage 2 expansion adjacent to the existing facility would take total capacity to 6,000 tonnes per annum from 2029. A definitive feasibility study is due in the third quarter of 2026, after which the project would still require financing and a final investment decision. The presentation puts initial Stage 2 capital expenditure at approximately US$215 million, based on the 2025 pre-feasibility study and excluding cost escalation and corporate costs.
Expansion economics depend on pricing and execution
AEM’s pre-feasibility case projects Stage 2 steady-state revenue of US$63.6 million and EBITDA of US$47.1 million using current CM Group pricing assumptions. Under long-term pricing assumptions, revenue rises to US$102 million and EBITDA to US$85.2 million. Those figures imply EBITDA margins of 74.0% and 83.7%, respectively, but remain study estimates rather than achieved operating results.
The company argues that its Quebec location gives it access to renewable hydroelectricity priced below US$0.05 per kilowatt-hour, locally sourced feedstock and a lower-cost production process. It says the plant is approximately 98% renewable-energy powered and is expected to sit in the bottom half of the global HPA cost curve. These advantages matter most if AEM can convert qualification activity into repeat orders while maintaining the product quality required by semiconductor and advanced-ceramics customers.
Semiconductor demand is the commercial focus
AEM is prioritising higher-purity 4N+ products as it targets applications including thermal fillers, ceramic components, chip packaging and other semiconductor manufacturing uses. The presentation also points to ultra-low alpha HPA containing less than one part per billion of uranium and thorium, a product aimed primarily at demanding semiconductor applications.
Managing Director and CEO Mick Adams said customers were concerned about HPA supply shortages and showed particular interest in advanced ceramics and ultra-low alpha products. The company expects three further distributor arrangements to be finalised, including two in China and one in Japan, while continuing industrial trials of its ultra-low alpha material.
Cash provides a base, not a complete funding plan
AEM reported A$23.7 million of cash and A$175.7 million of net assets at 30 June 2026, with A$120.5 million of plant substantially built and commissioned. That supports the current production ramp, but the proposed Stage 2 build carries a much larger capital requirement than the company’s disclosed cash balance. The presentation says the project’s economics may support a material debt component and potential Quebec government support, though neither financing outcome is assured.
The next evidence will come from the feasibility study, the 3N5+ commissioning programme and the conversion of industrial trials into contracted commercial volumes. Until those milestones arrive, AEM has a compelling supply-deficit narrative and a sizeable qualification pipeline, but the value of that pipeline will be determined by what customers actually buy rather than how many projects sit in the database.
Bottom Line?
AEM is moving from plant commissioning to the harder phase of proving repeatable commercial demand, with the Stage 2 funding decision likely to hinge on sales conversion and operating performance.
Questions in the middle?
- How many of the 38 industrial-trial projects will convert into recurring orders?
- Can AEM deliver 40 to 60 tonnes of second-half 2026 sales while ramping the new 3N5+ circuit?
- What funding mix will support the estimated US$215 million Stage 2 expansion?